The timing and frequency of trial inclusion in systematic reviews of type 2 diabetes drugs was associated with trial characteristics

Adam G. Dunn*, Liat Orenstein, Enrico Coiera, Kenneth D. Mandl, Florence T. Bourgeois

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'The timing and frequency of trial inclusion in systematic reviews of type 2 diabetes drugs was associated with trial characteristics'. Together they form a unique fingerprint.

Medicine & Life Sciences